Beta: Sign in
Shares outstandingAs of 2026-08-11 · filed common shares: 15.13M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 4.50%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 6.65%
Short ratioDays to cover, as published by FINRA: 4.60
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 60.50%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 55.60%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Avg volume (3 months)

Profitability

Gross margin: —
Operating margin (nine months)Nine months: 2024-01-01 to 2024-09-30 · Not annualized: -9793.10%
Net margin: —
EBITDA margin (nine months)Nine months: 2024-01-01 to 2024-09-30 · Not annualized: -9703.45%
Return on equityNet income (TTM to Jun 26) ÷ average shareholders equity: -1803.19%
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: -214.47%

Growth

Revenue growth (annual YoY): -100.00%
Revenue growth (latest qtr YoY): —
Revenue growth (fwd): Sign in
Net income growth (annual YoY): —
Net income growth (latest qtr YoY): —
EPS growth (fwd): Sign in
Net income growth (QoQ): —

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales

Price / operating cash flow

P/FCF

EV / revenue

EV / EBITDA

EPS (diluted, quarter)Quarter: 2026-01-01 to 2026-03-31 · Not annualized

-0.21

EPS (fwd)

Financial health

Cash & equivalentsas of Jun 26: $4.11M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $293.00K
Debt / equityas of Jun 26: 10.85%
Current ratioas of Jun 26: 2.09
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Jun 26: 2.02
Operating cash flowTTM to Jun 26: -$7.56M
Free cash flowUnadjusted FCF = CFO − capex · TTM to Jun 26: -$7.57M
TTM revenue / diluted share: —

BCDA stock Statistics — BioCardia, Inc. filings, insiders & smart money · Instaport